
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Nalpropion Pharmaceuticals, Inc. is a patient-focused biopharmaceutical company focused on the treatment of weight loss. Nalpropion was formed on April 17, 2018 as a joint venture among Pernix Therapeutics Holdings, Inc., Highbridge Capital Management, LLC and Whitebox Advisors LLC. Nalpropion was established for the purposes of purchasing substantially all commercial assets of Orexigen. Our team is creative, passionate, collaborative and determined to succeed. Nalpropion offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.
Pharmaceuticals
Nalpropion pharmaceuticals, inc's revenue is 11m - 100m
Nalpropion pharmaceuticals, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.